Efficacy and safety of azithromycin in Covid-19 patients: A systematic review and meta-analysis of randomized clinical trials.

Kamel, Ahmed M; Monem, Mona S A; Sharaf, Nour A; Magdy, Nada; Farid, Samar F

Kamel, Ahmed M; Monem, Mona S A; Sharaf, Nour A; Magdy, Nada; Farid, Samar F.

Afiliación

Kamel AM; Department of Clinical Pharmacy, College of Pharmacy, Cairo University, Cairo, Egypt.
Monem MSA; Department of Clinical Pharmacy, College of Pharmacy, Cairo University, Cairo, Egypt.
Sharaf NA; Department of Clinical Pharmacy, College of Pharmacy, Cairo University, Cairo, Egypt.
Magdy N; Department of Clinical Pharmacy, College of Pharmacy, Cairo University, Cairo, Egypt.
Farid SF; Department of Clinical Pharmacy, College of Pharmacy, Cairo University, Cairo, Egypt.

Rev Med Virol ; 32(1): e2258, 2022 01.

Article en En | MEDLINE | ID: mdl-34077600

Asunto(s)

Antibacterianos/uso terapéutico; Azitromicina/uso terapéutico; Tratamiento Farmacológico de COVID-19; Antibacterianos/efectos adversos; Azitromicina/efectos adversos; COVID-19/diagnóstico; Humanos; Persona de Mediana Edad; Ensayos Clínicos Controlados Aleatorios como Asunto; SARS-CoV-2

Palabras clave

Covid-19; azithromycin; efficacy; meta-analysis; mortality; safety; systematic review

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Azitromicina / Tratamiento Farmacológico de COVID-19 / Antibacterianos Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Systematic_reviews Límite: Humans / Middle aged Idioma: En Revista: Rev Med Virol Asunto de la revista: VIROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Egipto

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google